<scp>AT</scp>‐101 downregulates <scp>BCL</scp>2 and <scp>MCL</scp>1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and <scp>W</scp>aldenström macroglobulinaemia

Aneel Paulus(Mayo Clinic), Asher Chanan‐Khan(WinnMed)

British Journal of Haematology

November 17, 2013

10.1111/bjh.12633

Cited by 36

Related Papers

Targeted inhibition of the deubiquitinating enzymes, <scp>USP</scp>14 and <scp>UCHL</scp>5, induces proteotoxic stress and apoptosis in <scp>W</scp>aldenström macroglobulinaemia tumour cells

|British Journal of Haematology|2015|61

The Combination of the Proteasome Inhibitor Bortezomib and the Bcl-2 Antisense Molecule Oblimersen Sensitizes Human B-Cell Lymphomas to Cyclophosphamide

|Clinical Cancer Research|2006|46